Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Tanimilast by Chiesi Farmaceutici for Chronic Bronchitis: Likelihood of Approval
Tanimilast is under clinical development by Chiesi Farmaceutici and currently in Phase III for Chronic Bronchitis. According to GlobalData, Phase...
Tanimilast by Chiesi Farmaceutici for Chronic Obstructive Pulmonary Disease (COPD): Likelihood of Approval
Tanimilast is under clinical development by Chiesi Farmaceutici and currently in Phase III for Chronic Obstructive Pulmonary Disease (COPD). According...
Tanimilast by Chiesi Farmaceutici for Asthma: Likelihood of Approval
Tanimilast is under clinical development by Chiesi Farmaceutici and currently in Phase II for Asthma. According to GlobalData, Phase II...